Select Bibliography

 Search for any words:
Excel csv Word PDF RIS
  Filter by any of these (after searching):
      
Year
      
PubType
      
Endpoint
      
Analysis
      
Datasharing
      
Committee
      
Program
      
Meeting
      
Funding
  Mrózek, Krzysztof                    

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 94 items

Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720 Google Scholar
,  ,  ... -  ASCO   -  J. Clin. Oncol.   -  2008    
Abstract -  Secondary -  Primary -  Leukemia -  CALGB-10201 ,  CALGB-10502 ,  CALGB-10503 ,  CALGB-10603 ,  CALGB-19808 ,  CALGB-8525 ,  CALGB-8923 ,  CALGB-9022 ,  CALGB-9222 ,  CALGB-9420 ,  CALGB-9621 ,  CALGB-9720
Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study    QxMD    Google Scholar
,  ,  ... -    -  Haematologica   -  2011    
Manuscript -  Secondary -  Primary -  Leuk Corr Sci -  C8525 ,  CALGB-10201 ,  CALGB-19808 ,  CALGB-20202 ,  CALGB-20502 ,  CALGB-8461 ,  CALGB-8923 ,  CALGB-9420 ,  CALGB-9621 ,  CALGB-9665 ,  CALGB-9720
Mutations associated with a 17-gene leukemia stem cell score and the score’s prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia    QxMD    Google Scholar
,  ,  ... -    -  Haematologica   -  2020    
Manuscript -  Secondary-not-in-original -  Primary -  Leuk Corr Sci -  CALGB-8461 ,  C8621 ,  C8721 ,  CALGB-10201 ,  CALGB-10502 ,  CALGB-10503 ,  CALGB-10603 ,  CALGB-11001 ,  CALGB-11002 ,  CALGB-19808 ,  CALGB-20202 ,  CALGB-8525 ,  CALGB-8821 ,  CALGB-8923 ,  CALGB-9022 ,  CALGB-9120 ,  CALGB-9222 ,  CALGB-9420 ,  CALGB-9621 ,  CALGB-9665 ,  CALGB-9720
Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies    QxMD    Google Scholar
,  ,  ... -    -  Leukemia   -  2018    
Manuscript -  Secondary-not-in-original -  Meta-Analysis -  Leuk Corr Sci -  C8461 ,  C8525 ,  C8821 ,  C9665 ,  CALGB-10201 ,  CALGB-10502 ,  CALGB-11001 ,  CALGB-11002 ,  CALGB-20202 ,  CALGB-8461 ,  CALGB-8923 ,  CALGB-9420 ,  CALGB-9720
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study    QxMD    Google Scholar
,  ,  ... -    -  Blood   -  2008    
Manuscript -  Secondary -  Primary -  Leuk Corr Sci -  CALGB-19808 ,  CALGB-20502 ,  CALGB-8461 ,  CALGB-9621 ,  CALGB-9665
RUNX1 Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures    QxMD    Google Scholar
,  ,  ... -    -  J. Clin. Oncol.   -  2012    
Manuscript -  Secondary -  Primary -  Leuk Corr Sci -  C8525 ,  CALGB-8461 ,  CALGB-8923 ,  CALGB-9420 ,  CALGB-9621 ,  CALGB-9665 ,  CALGB-9720 ,  CALGB-10201 ,  CALGB-19808 ,  CALGB-20202
Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance)    QxMD    Google Scholar
,  ,  ... -    -  Haematologica   -  2016    
Manuscript -  Secondary-not-in-original -  Meta-Analysis -  Leuk Corr Sci -  CALGB-10201 ,  CALGB-10502 ,  CALGB-10503 ,  CALGB-10603 ,  CALGB-10801 ,  CALGB-11002 ,  CALGB-19808 ,  CALGB-8461 ,  CALGB-8525 ,  CALGB-8923 ,  CALGB-9022 ,  CALGB-9621 ,  CALGB-9720
Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia    QxMD    Google Scholar
,  ,  ... -    -  Proc. Natl. Acad. Sci. U.S.A   -  2017    
Manuscript -  Secondary -  Primary -  Leuk Corr Sci -  CALGB-10201 ,  CALGB-10503 ,  CALGB-10603 ,  CALGB-19808 ,  CALGB-20202 ,  CALGB-8461 ,  CALGB-8525 ,  CALGB-8923 ,  CALGB-9022 ,  CALGB-9120 ,  CALGB-9222 ,  CALGB-9420 ,  CALGB-9665 ,  CALGB-9720
inv(16)/t(16;16) acute myeloid leukemia with non–type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations    QxMD    Google Scholar
,  ,  ... -    -  Blood   -  2013    
Manuscript -  Secondary -  Primary -  Leuk Corr Sci -  CALGB-8461 ,  CALGB-8525 ,  CALGB-8821 ,  CALGB-8923 ,  CALGB-9022 ,  CALGB-9120 ,  CALGB-9222 ,  CALGB-9621 ,  CALGB-9720 ,  CALGB-19808 ,  CALGB-10201 ,  CALGB-10502 ,  CALGB-10503 ,  CALGB-10603
Allogeneic Hematopoietic Cell Transplantation Compared to Chemotherapy Consolidation in older Acute Myeloid Leukemia (AML) Patients 60–75 Years in First Complete Remission (CR1): An Alliance (A151509), SWOG, ECOG-ACRIN and CIBMTR Study    QxMD    Google Scholar
,  ,  ... -    -  Leukemia   -  2019    
Manuscript -  Primary -  Primary -  Older Adult -  A151509 ,  CALGB-10502 ,  CALGB-10801 ,  CALGB-11001 ,  CALGB-11002 ,  E3999 ,  S0432 ,  S0703
Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia    QxMD    Google Scholar
,  ,  ... -    -  Clin. Cancer Res.   -  2019    
Manuscript -  Secondary-not-in-original -  Meta-Analysis -  Leuk Corr Sci -  C8721 ,  CALGB-10201 ,  CALGB-10502 ,  CALGB-10503 ,  CALGB-10603 ,  CALGB-19808 ,  CALGB-20202 ,  CALGB-8461 ,  CALGB-8525 ,  CALGB-8821 ,  CALGB-8923 ,  CALGB-9022 ,  CALGB-9222 ,  CALGB-9420 ,  CALGB-9621 ,  CALGB-9665 ,  CALGB-9720


Copyright ©2013 - 2022 Alliance Foundation. All rights reserved.